ASPEN/AND Consensus Criteria for Disease-Related Malnutrition
To diagnose malnutrition using the ASPEN/AND consensus criteria, at least two of the following six clinical characteristics must be present: insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, fluid accumulation (edema), and reduced hand-grip strength 1.
The Six Diagnostic Characteristics
The ASPEN (American Society for Parenteral and Enteral Nutrition) and Academy of Nutrition and Dietetics (AND) established these standardized criteria to provide an objective, evidence-based approach to malnutrition diagnosis across clinical settings 1:
1. Insufficient Energy Intake
- Documented inadequate oral, enteral, or parenteral nutrition intake relative to estimated requirements
2. Weight Loss
- Unintentional loss documented over a specific time period
- Severity grading depends on percentage lost and timeframe
3. Loss of Muscle Mass
- Assessed through physical examination (temporal wasting, clavicular prominence, shoulder/scapular bone definition, interosseous muscle wasting)
- Can be quantified through imaging or bioelectrical impedance when available
4. Loss of Subcutaneous Fat
- Evaluated via physical examination at orbital, triceps, and ribs areas
- Visible depletion of fat stores
5. Fluid Accumulation
- Presence of edema or ascites
- May mask weight loss and complicate assessment
6. Reduced Hand-Grip Strength
- Measured using a dynamometer
- Gender- and age-specific cut-points applied
- Reflects functional muscle capacity
Diagnostic Algorithm
Step 1: Evaluate all six characteristics systematically during nutrition assessment
Step 2: Document presence or absence of each characteristic with objective measurements when possible
Step 3: If ≥2 characteristics are present → Malnutrition diagnosis confirmed
Step 4: Grade severity (mild, moderate, severe) based on the degree of abnormality in each characteristic present
Disease-Related Malnutrition Context
The ASPEN/AND criteria specifically recognize that inflammation is a critical driver of disease-related malnutrition (DRM) 1. DRM manifests in two forms:
- Chronic DRM with inflammation (cachexia): Milder inflammatory response in conditions like cancer, chronic organ failure
- Acute disease/injury-related malnutrition: Strong inflammatory response in critical illness, major surgery, severe infection
The inflammatory component triggers anorexia, accelerated tissue breakdown, and altered body composition—leading to decreased fat-free mass and impaired physical/mental function 1.
Clinical Application Considerations
Prevalence varies by setting: Studies show ASPEN/AND criteria identify 34-67% of hospitalized patients as malnourished, depending on population 2, 3, 4. This is notably higher than other diagnostic systems like ESPEN (which identified only 20% in one comparative study) 2.
Prognostic validity: Malnutrition diagnosed by ASPEN/AND criteria predicts:
- 1.4× increased risk of prolonged hospital stay 4
- 1.4× increased risk of readmission 4
- 2.8× increased in-hospital mortality 5
- 5-6× increased risk of death within 6 months 4
Common pitfall: Fluid accumulation can mask weight loss and muscle wasting, making visual assessment of these characteristics more challenging. Always assess multiple body sites and consider serial measurements 1.
Practical note: While hand-grip strength adds objectivity, studies demonstrate the criteria maintain satisfactory validity even without this measurement when the other five characteristics are thoroughly evaluated 4. However, including grip strength when feasible strengthens diagnostic accuracy.
Documentation importance: The criteria's objectivity facilitates consistent documentation for insurance reimbursement and interdisciplinary communication 6. Ensure specific measurements and observations are recorded for each characteristic assessed.
The ASPEN/AND approach differs from other systems (like GLIM) by including edema and grip strength while emphasizing the phenotypic manifestations of malnutrition rather than solely anthropometric cut-points 6. This makes it particularly applicable across diverse clinical populations where inflammation-driven malnutrition predominates.